Cargando…

Follow‐up of late‐onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles

BACKGROUND: Late‐onset Pompe disease (LOPD) is a genetic disorder characterized by progressive degeneration of the skeletal muscles produced by a deficiency of the enzyme acid alpha‐glucosidase. Enzymatic replacement therapy with recombinant human alpha‐glucosidase seems to reduce the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuñez‐Peralta, Claudia, Alonso‐Pérez, Jorge, Llauger, Jaume, Segovia, Sonia, Montesinos, Paula, Belmonte, Izaskun, Pedrosa, Irene, Montiel, Elena, Alonso‐Jiménez, Alicia, Sánchez‐González, Javier, Martínez‐Noguera, Antonio, Illa, Isabel, Díaz‐Manera, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432562/ https://www.ncbi.nlm.nih.gov/pubmed/32129012 http://dx.doi.org/10.1002/jcsm.12555

Ejemplares similares

Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
por: Figueroa-Bonaparte, Sebastian, et al.
Publicado: (2018)

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients
por: Reyes-Leiva, David, et al.
Publicado: (2021)

Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
por: Nuñez-Peralta, Claudia, et al.
Publicado: (2021)

Corrigendum: Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
por: Nuñez-Peralta, Claudia, et al.
Publicado: (2021)

Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function
por: Figueroa-Bonaparte, Sebastián, et al.
Publicado: (2016)

PDGF-BB serum levels are decreased in adult onset Pompe patients
por: Fernández-Simón, Esther, et al.
Publicado: (2019)

Identification of serum microRNAs as potential biomarkers in Pompe disease
por: Carrasco‐Rozas, Ana, et al.
Publicado: (2019)

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

Muscle MRI in muscular dystrophies
por: Díaz-Manera, Jordi, et al.
Publicado: (2015)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
por: Prater, Sean N, et al.
Publicado: (2013)

Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
por: Mitja, Jevnikar, et al.
Publicado: (2015)

Skeletal muscle metabolism during prolonged exercise in Pompe disease
por: Preisler, Nicolai, et al.
Publicado: (2017)

Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Moriggi, Manuela, et al.
Publicado: (2021)

Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease
por: Wang, Jason, et al.
Publicado: (2021)

Dysregulation of Metabolism and Proteostasis in Skeletal Muscle of a Presymptomatic Pompe Mouse Model
por: Rohm, Marlena, et al.
Publicado: (2023)

Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy
por: Gallardo, Eduard, et al.
Publicado: (2011)

Dynamic respiratory muscle function in late-onset Pompe disease
por: Smith, Barbara K., et al.
Publicado: (2019)

Limitations of muscle biopsy in Pompe disease
por: Vissing, John
Publicado: (2013)

Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing
por: Lévesque, Sébastien, et al.
Publicado: (2016)

Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients
por: Carlier, Pierre G., et al.
Publicado: (2015)

TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle
por: Sato, Yohei, et al.
Publicado: (2016)

Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
por: Jackson, David G., et al.
Publicado: (2023)

A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells
por: Yoshida, Takeshi, et al.
Publicado: (2017)

GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
por: van der Wal, Erik, et al.
Publicado: (2017)

STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
por: Gutschmidt, Kristina, et al.
Publicado: (2021)

Glycogenosome accumulation in the arrector pili muscle in Pompe disease
por: Katona, Istvan, et al.
Publicado: (2014)

The impact of Pompe disease on smooth muscle: a review
por: MCCALL, Angela L., et al.
Publicado: (2019)

Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
por: De Luna, Noemí, et al.
Publicado: (2017)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

Hydrostatic Isolated Limb Perfusion with Adeno-associated Virus Vectors Enhances Correction of Skeletal Muscle in Pompe Disease
por: Sun, Baodong, et al.
Publicado: (2010)

Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease
por: Boentert, Matthias, et al.
Publicado: (2016)

Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy
por: Gruhn, Kai Michael, et al.
Publicado: (2015)

Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders
por: Pedersen, Jonas Jalili, et al.
Publicado: (2023)

Degeneration of muscle spindles in a murine model of Pompe disease
por: Watkins, Bridgette, et al.
Publicado: (2023)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

Fiber Type Conversion by PGC-1α Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle
por: Takikita, Shoichi, et al.
Publicado: (2010)

Identification of Atypical Peri-Nuclear Multivesicular Bodies in Oxidative and Glycolytic Skeletal Muscle of Aged and Pompe's Disease Mouse Models
por: Neel, Brian A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ajdia77ubbqc2fpfohv2dtukfr